Why the study?
Does diabetic autonomic neuropathy impair human pancreatic polypeptide secretion in response to a standard mixed meal?
Does diabetic autonomic neuropathy impair human pancreatic polypeptide secretion in response to a standard mixed meal?
Diabetic autonomic neuropathy is associated with impaired early human pancreatic polypeptide secretion in response to food, suggesting hPP response could serve as a marker for parasympathetic impairment.
Answers are grounded in this paper and cite their sources.
Blunted early hPP response was associated with diabetic autonomic neuropathy; supports hPP as parasympathetic marker but leaves clinical utility open.
In normal subjects, the early human pancreatic polypeptide (hPP) increase induced by food is mainly dependent on vagal activity. Parasympathetic function and plasma hPP response to a standard mixed meal were evaluated in 10 long term insulin-dependent (type I) diabetic patients (group A), 6 age-matched newly diagnosed type I diabetic patients (group B), and 8 normal subjects. The indices of vagal function (beat to beat heart rate variation during deep breathing and the Valsalva maneuver) were uniformly altered in group A, while they were in the normal range in group B, thus excluding in these latter patients the presence of vagal damage. Plasma hPP in response to standard mixed meal was measured at 5, 15, 30, 60, and 120 min. Fasting plasma hPP concentrations (determined by RIA) in groups A and B (mean +/- SEM, 113 +/- 21 and 83 +/- 21 pg/ml, respectively) did not significantly differ from normal (59 +/- 12 pg/ml). In group A, the initial meal-induced hPP increase was significantly lower than normal (5 min, 139 +/- 12; 15 min, 173 +/- 24; 30 min, 137 +/- 17 pg/ml; P less than 0.01 vs. 5 min, 412 +/- 76; 15 min, 446 +/- 57; 30 min, 325 +/- 56 pg/ml). All group B patients had a marked early increase in the peptide, similar to that in the normal subjects. These results suggest that diabetic autonomic neuropathy is associated with dysfunction of hPP secretion, and the evaluation of hPP in response to SMM may be considered a sensitive and nonstressful method for the assessment of parasympathetic impairment in diabetes.
No takes yet. Share an insight, caveat, or question.
Lugari et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: